{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.526.3.402",
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.402",
  "identifier": [ {
    "system": "urn:ietf:rfc:3986",
    "value": "2.16.840.1.113883.3.526.3.402"
  } ],
  "version": "20170908",
  "name": "InfluenzaVaccination",
  "title": "Influenza Vaccination",
  "status": "active",
  "experimental": false,
  "publisher": "NLM",
  "expansion": {
    "identifier": "20200507",
    "timestamp": "2021-01-14T20:59:46-07:00",
    "contains": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90630",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90653",
      "display": "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90654",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90655",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90656",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90657",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90658",
      "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90661",
      "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90662",
      "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90666",
      "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90667",
      "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90668",
      "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90673",
      "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90674",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90682",
      "display": "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90685",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90686",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90687",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90688",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90689",
      "display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90694",
      "display": "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "http://www.ama-assn.org/go/cpt",
      "version": "2020",
      "code": "90756",
      "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "G0008",
      "display": "Administration of influenza virus vaccine"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2034",
      "display": "Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2035",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2036",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2037",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2038",
      "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
    }, {
      "system": "urn:oid:2.16.840.1.113883.6.285",
      "version": "2020",
      "code": "Q2039",
      "display": "Influenza virus vaccine, not otherwise specified"
    }, {
      "system": "http://snomed.info/sct",
      "version": "2019-09",
      "code": "86198006",
      "display": "Influenza vaccination (procedure)"
    } ]
  }
}